Learn about the requirements laid out by US (USP), European (EP), and Japanese (JP) Pharmacopoeia standards and the most recent USP <788> (April 2007), EP 5.1 and JP 15 release information. These standards demand that injectable solutions are effectively monitored for microcontamination, specifically non-soluble particulates.